Skip to main content
Premium Trial:

Request an Annual Quote

Italian Organizations Ink Cancer Biomarker Deals with UK Firms

NEW YORK (GenomeWeb) – TTFactor — the technology transfer firm of the European Institute of Oncology and the FIRC Institute of Molecular Oncology — investment firm BioVitas Capital, and the University of Milan today announced two deals to develop genomic biomarkers for lung, breast, and ovarian cancers.

In one agreement, the parties will collaborate with BioVitas-funded startup Gensignia, based in London, to develop microRNA-based signatures for detecting lung, breast, ovarian, and other cancers. The European Institute of Oncology, FIRC, and the University of Milan performed the original research, which is now being validated on a large cohort of patients in a clinical study sponsored by the European Institute of Oncology.

In a second deal, the parties are working with UK firm Tiziana Life Sciences, also a BioVitas-funded firm, to validate a gene signature of breast cancer stem cells. The agreement is aimed at defining better treatment options by genetically profiling patients. Tiziana discovers and develops molecules associated with cancer, with a particular emphasis on metastatic cancers.

Terms of the agreements were not disclosed.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.